New Chemical DNA Analysis Without Enyzmes For Safer and Quicker DNA Testing For Genetic Diseases
Basically, the cost of running typical DNA test is rather expensive due to the use of biological enzymes as reagents but running a newly-developed chemical DNA analysis able to reduce the cost of genetic screening test as it bypasses the need for such expensive components.
Based on a research in University of Edinburgh, without the use of these enzymes in this current test in Down’s Syndrome has produced remarkable results:
Enzyme-based technologies of genetic mapping cannot test for diseases that are inherited such as Down’s Syndrome.
Furthermore, the current test for Down’s Syndrome carries a one percent risk of abortion.
The new test could be developed to diagnose the foetus without such a risk.
Source: The Journal
Here are the “impact” of the latest development on this current chemical DNA analysis:
- Safer and quicker test for genetic disease like Down’s Syndrome
- Improve personalized treatment in terms of developing important applications for personal medicine
- A solution for inconclusive testing – a problem in forensic DNA analysis
via The Journal
Picture courtesy of GE Healthcare